Emerald Mutual Fund Advisers Trust 89bio, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.23 Billion
- Q1 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in 89bio, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 1,082,973 shares of ETNB stock, worth $8.99 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
1,082,973Holding current value
$8.99 Million% of portfolio
0.64%Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
177Shares Held
127MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$137 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$118 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$84.7 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$62.1 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$58.2 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $386M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...